Related Experiment Video

Updated: Aug 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Public health management in invasive meningococcal diseases]

I Ehrhard1, U Arndt

  • 1Landesuntersuchungsanstalt für das Gesundheits- und Veterinärwesen Sachsen, Dresden. ingrid.ehrhard@lua.sms.sachsen.de

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|December 21, 2004
PubMed

Insights

Public health officials are addressing rising invasive meningococcal disease in Europe. This workshop focused on managing meningococcal disease, particularly serogroup C, and vaccination strategies in Germany and Switzerland.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Management

Context:

  • The 54th Scientific Congress of the German Professional Association of Public Health Service Physicians and Dentists hosted an international workshop on "Public Health Management of invasive Meningococcal Disease."
  • Recent epidemiological shifts in Europe show a significant increase in meningococcal serogroup C cases in various regions.
  • This rise prompted the Netherlands to implement a conjugated meningococcal vaccine program for children aged 1-18 and Switzerland to introduce regional vaccination programs.

Purpose:

  • To discuss the evolving epidemiology of invasive meningococcal disease in Europe.
  • To review and compare public health management strategies for meningococcal disease, including vaccination, in Germany, the Netherlands, and Switzerland.
  • To present the epidemiological situation and recommended prophylaxis regimens for meningococci in Germany.

Summary:

  • The workshop highlighted increased incidence of meningococcal serogroup C disease across Europe.
  • The Netherlands and Switzerland have implemented vaccination programs in response to rising cases.
  • Germany's epidemiological status and prophylaxis recommendations were presented, noting broader vaccination indications in Switzerland.

Impact:

  • Informed public health strategies for managing invasive meningococcal disease.
  • Provided insights into the effectiveness and necessity of vaccination programs for meningococcal serogroup C.
  • Facilitated international collaboration and knowledge exchange on meningococcal disease control.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...